Azilsartan dosage forms and strengths

Revision as of 22:11, 19 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Azilsartan}} {{CMG}}; {{AE}} {{SS}} ==Dosage Forms and Strengths== Edarbi is supplied as white to nearly white round tablets in the following dosage strengths: ...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Azilsartan
EDARBI® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Azilsartan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Dosage Forms and Strengths

Edarbi is supplied as white to nearly white round tablets in the following dosage strengths:

•

  • 40-mg tablets - debossed "ASL" on one side and "40" on the other

•

  • 80-mg tablets - debossed "ASL" on one side and "80" on the other[1]

References

  1. ↑ "EDARBI (AZILSARTAN KAMEDOXOMIL) TABLET [TAKEDA PHARMACEUTICALS AMERICA, INC.]". Retrieved 19 February 2014.
Retrieved from "https://www.wikidoc.org/index.php?title=Azilsartan_dosage_forms_and_strengths&oldid=945338"